Suchergebnisse - "IFN-β-1a"

PubPharm (7)

1

Combination therapy of IFNβ1 with lopinavir-ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients

enthalten in: International immunopharmacology | 2021

von Baghaei, P. | Dastan, F. | Marjani, M. | +14

2

Severe Necrosis and Cellulitis Complicating Treatment with Interferon β-1a

enthalten in: Acta neurologica Taiwanica | 2020

von Chang, C. | Lin, C. | Su, J.

3

Toll-like receptor (TLR)7 and TLR9 agonists enhance interferon (IFN) beta-1a's immunoregulatory effects on B cells in patients with relapsing-remitting multiple sclerosis (RRMS)

enthalten in: Journal of neuroimmunology | 2016

von Tao, Y. | Zhang, X. | Markovic-Plese, S.

4

Interferon-β 1a Modulates Expression of RAGE but Not S100A12 and Nuclear Factor-κB in Multiple Sclerosis Patients

enthalten in: Neuroimmunomodulation | 2016

von Asadikaram, G. | Noroozi, S. | Ebrahimi Meimand, H. | +5

5

Multiple sclerosis patients treated with intramuscular IFN-β-1a autoinjector in a real-world setting : prospective evaluation of treatment persistence, adherence, quality of life and satisfaction

enthalten in: Expert opinion on drug delivery | 2015

von Hupperts, R. | Becker, V. | Friedrich, J. | +4

6

Single-use autoinjector for peginterferon-β1a treatment of relapsing-remitting multiple sclerosis : safety, tolerability and patient evaluation data from the Phase IIIb ATTAIN study

enthalten in: Expert opinion on drug delivery | 2014

von Seddighzadeh, A. | Hung, S. | Selmaj, K. | +4

7

Efficacy and safety of subcutaneous interferon-β-1a in patients with a first demyelinating event and early multiple sclerosis

enthalten in: Expert opinion on biological therapy | 2014

von Freedman, M.

1
[1]